NCT06735937

Brief Summary

In this study, we aim to compare the effects of end-tidal controlled and manually controlled low-flow anesthesia on anesthetic agent consumption in elective surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

December 11, 2024

Last Update Submit

December 11, 2024

Conditions

Low-flow Anesthesia

Keywords

end-tidal controlledlow flow anesthesiaconsumption

Outcome Measures

Primary Outcomes (1)

  • anesthesic gas consumption

    At the end of the surgery

Study Arms (2)

End-tidal controlled

EXPERIMENTAL

Patients ventilated using end tidal controlled low-flow anesthesia

Other: Low flow anesthesia

Manually controlled

EXPERIMENTAL

Patients ventilated using manually controlled low flow anesthesia

Other: Low flow anesthesia

Interventions

Low flow anesthesiaOTHER

Anesthesia management by using low flow anesthesia

End-tidal controlledManually controlled

Eligibility Criteria

Age18 Years - 73 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II
  • Aged between18-73

You may not qualify if:

  • heart failure
  • liver disease
  • lung disease
  • kidney disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elzem Sen

Gaziantep, Sehitkamil, 5327842151, Turkey (Türkiye)

Location

Study Officials

  • Elzem Sen, Assoc Prof

    University of Gaziantep

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof

Study Record Dates

First Submitted

December 11, 2024

First Posted

December 16, 2024

Study Start

September 1, 2019

Primary Completion

August 1, 2020

Study Completion

August 31, 2020

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)